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S U M M A R Y
Objectives: An epidemic of Ross River virus (RRV) occurred in the South Paciﬁc in 1979–1980, but RRV has
not been thought to occur endemically outside Australia and Papua New Guinea. A seroprevalence study
was conducted to determine whether RRV has circulated in American Samoa since 1980.
Methods: RRV ELISA IgG was performed on 200 serum samples collected in American Samoa in 2010;
seroneutralization tests were performed on 60 representative samples.
Results: Of 196 available ELISA IgG results, 145 (74%, 95% conﬁdence interval 67–80%) were seropositive.
Of the 60 samples subjected to seroneutralization testing, none of the 15 ELISA IgG-negative and 16 of the
45 ELISA IgG-positive samples neutralized RRV. ELISA IgG seroprevalence was higher in persons born
before/during the 1979–1980 RRV outbreak (78.3%), but was also high (63.0%) in people born after the
outbreak who had lived their entire lives in American Samoa.
Conclusions: This study provides serological evidence that RRV circulation is likely to have occurred in
American Samoa after 1980. Considering there are no marsupials in American Samoa, this ﬁnding implies
that other species are capable of acting as reservoir hosts and indicates the potential for RRV to circulate
in a much wider area than those currently recognized.
© 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Ross River virus (RRV) is an arthropod-borne virus (arbovirus)
of the Alphavirus genus (Togaviridae family) endemic to Australia
and Papua New Guinea. Macropod marsupials (kangaroos,
wallabies) are the primary reservoir hosts and Aedes and Culex
mosquitoes are the vectors.1–3 In Australia, approximately
5000 infections are notiﬁed yearly.2 Although 55–75% of cases
are asymptomatic, RRV can cause debilitating joint pain lasting for
months. Common symptoms include arthralgia, fever, fatigue, and
a maculopapular rash.2
A large virgin soil epidemic occurred in 1979–1980 in the Paciﬁc
Island Countries and Territories (PICTs), with more than 500* *Corresponding author. Tel.: +61 402134878; Fax: +61 7 3069 7159.
E-mail address: colleen.lau@anu.edu.au (C. Lau).
http://dx.doi.org/10.1016/j.ijid.2017.01.041
1201-9712/© 2017 The Author(s). Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).000 cases reported across the region and dramatic attack rates in
American Samoa (44%), Fiji (90%), the Cook Islands (69%), and New
Caledonia (33%).4–6 The outbreak was believed to have been
initiated by a viraemic Australian who had travelled to Fiji.4 During
epidemics, human–mosquito–human transmission could occur,
bypassing the reservoir hosts.2 Soon after the outbreak, a study in
American Samoa found serological evidence of infection in dogs,
pigs, chickens, and rats.6 This ﬁnding was consistent with
knowledge that non-marsupials can become infected during
epidemics and potentially act as short-term amplifying hosts,
but most will be dead-end hosts that play no further role in
transmission. Considering that marsupials, the only known
reservoirs for RRV, are absent from the PICTs, it was assumed
that RRV transmission in the region ceased soon after the outbreak.
Since 1980, no outbreaks of RRV have been recorded in the
PICTs, but there have been ongoing concerns about low-level
endemic transmission because of reports of RRV infections inciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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New Zealanders were diagnosed with RRV infection after visiting
Fiji. The patients had not travelled to other countries with RRV and
there is no local transmission of any mosquito-borne diseases in
New Zealand.7,8 RRV infections were also reported in Canadians
and a German after visiting the PICTs.7 A recent seroprevalence
study in French Polynesia found that 42.4% of 132 blood donors
who had not travelled abroad were seropositive for RRV by ELISA
IgG,9 providing further evidence of endemic circulation of RRV in
the PICTs.
Marsupials are absent in French Polynesia and Fiji, suggesting
that non-marsupials can potentially act as reservoir hosts for RRV.
It therefore appears that the known endemic area for RRV has
undergone a signiﬁcant range expansion, bringing RRV into the
realm of an emerging infectious disease, which has global public
health implications. This seroprevalence study was conducted in
the islands of American Samoa to seek further evidence for RRV
transmission in the PICTs after the 1979–1980 outbreak.
Methods
Study location and setting
American Samoa consists of ﬁve small remote islands in the
South Paciﬁc, with a highly stable human population of 56 000. The
only endemic mammals are bats, and introduced feral mammals
are limited to three species of rodent.10 Also present are pigs, dogs,
cats, and very few cows and horses. Mosquitoes are abundant in
American Samoa, including Aedes aegypti and Aedes polynesiensis
(both with vectorial capacity to transmit RRV),1,11 as well as Culex
annulirostris, an important RRV vector in Australia.2,12
Serum bank
With human research ethics approval from the American
Samoa Institutional Review Board, RRV serology was performed on
200 serum bank samples collected for a leptospirosis study in
2010.13,14 The community-based cross-sectional study included
adults (aged 18 years and over) from all ﬁve inhabited islands of
American Samoa. The study was designed to include a representa-
tive sample of the adult population in American Samoa, and
consisted of random sampling on the main island of Tutuila (where
>95% of the population reside) and the adjacent island of Aunu’u,
and convenience sampling on the very small and remote Manu’a
islands. Questionnaires were used to collect data on demographics,
occupation, recreational activities, and household characteristics.
Serology
Serological analysis for RRV was conducted at the Institut Louis
Malardé, French Polynesia. Immunoglobulin class G antibodies
(IgG) to RRV were detected by indirect ELISA, using recombinant
antigens and protocol as reported previously.9 Brieﬂy, sera were
diluted 1:400 and added to wells of 96-well plates coated with RRV
recombinant antigens (RR.sE2-SNAP). For each sample, speciﬁc
absorbance was determined by deducting the absorbance value
obtained with the control antigen (SNAP) from the absorbance
value found with RR.sE2-SNAP recombinant antigens. Sera with
speciﬁc absorbance values 0.2 were considered positive for the
presence of IgG.
Seroneutralization tests
ELISA results were validated by testing a subset of the samples
with RRV neutralization. As the ELISA protocol used in this study is
based on the use of a recombinant antigen designed to berecognized as a target epitope by IgG antibodies that are very
speciﬁc to RRV but that only represent a limited part of the whole
population of anti-RRV antibodies, a subset of the initial samples
were also submitted to neutralization assay to obtain additional
information on the ability of the global population of anti-RRV
antibodies to neutralize RRV. Seroneutralization assays were also
conducted for chikungunya virus (CHIKV), another alphavirus,
because it is antigenically similar to RRV and has circulated in the
PICTs since 2011. Only one third of the samples were tested by
neutralization because of limited resources. Fifteen samples with
negative (speciﬁc absorbance <0.2), 15 with weak (speciﬁc
absorbance 0.2 to 0.4), 15 with intermediate (speciﬁc absorbance
between 0.4 to 0.8), and 15 with strong (speciﬁc absorbance >0.8)
RRV ELISA results were selected randomly to provide a panel of
sera with different IgG signal intensities. Neutralization tests were
performed at Aix–Marseille University in France, in duplicate in a
96-well plate format using protocols and control sera from the
French National Reference Laboratory for Arboviruses. Two-fold
dilutions (1:20–1:160) were incubated (37 C, 1 h) with 50 TCID50
of RRV (strain 5281 v) or CHIKV (strain Haiti 5/2014), inoculated in
duplicate onto monolayers of Vero cells (ATCC-CCL-81) and
incubated at 37 C for 5 days. Dilutions of viruses and sera alone
were used as controls. Endpoints were dilutions that completely
inhibited the cytopathic effects in the cell culture wells.
Statistical analyses
The Chi-square test or Fisher’s exact test was used to identify
signiﬁcant associations between independent variables and the
presence of RRV IgG antibodies. Independent variables examined
included sex, birth year, living entire life in American Samoa, work
location, and participation in outdoor activities (hiking, swimming,
kayaking, and gardening). Birth year was classiﬁed into 1980 and
before (born before or during the outbreak) and 1981–1993 (born
after the outbreak). Work location was classiﬁed into indoor,
outdoor, mixed indoor/outdoor, and tuna cannery (the major non-
government employer in American Samoa). Variables with a p-
value of <0.05 were selected for further analyses using univariate
logistic regression, and statistically signiﬁcant results are reported
in Table 1. Independent variables associated with the outcome by a
likelihood ratio test p-value of <0.1 were subjected to a stepwise
backward elimination process (p < 0.05) to select the ﬁnal
variables for the multivariable model. Statistically signiﬁcant odds
ratios (OR) are indicated in the Table. Stata version 11.1 software
(StataCorp, College Station, TX, USA) was used for the statistical
analyses; p-values of <0.05 were considered statistically signiﬁ-
cant.
Results
RRV ELISA IgG results were available for 196 samples, of which
145 (74%, 95% conﬁdence interval (CI) 67.2–80.0%) were seroposi-
tive (mean speciﬁc absorbance 0.75, range 0.21–2.61). All of the 15
samples with negative RRV ELISA IgG results (speciﬁc absorbance
<0.2) were also negative by RRV neutralization test. Of the positive
RRV ELISA IgG samples with speciﬁc absorbance of 0.2 to 0.4, 0.4
to 0.8, and >0.8, 20% (3/15), 40% (6/15), and 47% (7/15) neutralized
RRV, respectively. The results of the neutralization tests for RRV are
summarized in Figure 1. All 60 samples were negative on CHIKV
neutralization tests.
Table 1 summarizes the study population and risk factors
associated with the presence of RRV ELISA IgG. Seroprevalence was
lower in females, indoor workers, and those who had never
partaken in hiking or gardening. A higher seroprevalence was
found in persons involved in outdoor activities, which is consistent
with a mosquito-borne infection. Seroprevalence was higher in
Figure 2. Ross River virus seroprevalence by birth year, and number of samples
tested in each age group.
Figure 1. Ross River virus neutralization results for a subset of 60 samples:
15 samples each with negative (<0.2), weak (0.2 to 0.4), intermediate (0.4 to
0.8), and strong (>0.8) speciﬁc absorbance for RRV ELISA.
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compared to those born after 1980 (65.2%). RRV seroprevalence
was 63.0% in those born after 1980 who had lived their entire lives
in American Samoa. Figure 2 shows RRV ELISA IgG seroprevalence
by birth year. Seroprevalence was 45% in people born between
1991 and 1993, 75% in people born between 1988 and 1990, and
80% in people born between 1985 and 1988, suggesting that RRV
circulated in American Samoa long after the 1979–1980 outbreak.
Discussion
High RRV seroprevalence in persons born after 1980 who had
only lived in American Samoa provides serological evidence that
RRV circulation is likely to have occurred after 1980. All of the
60 samples subjected to seroneutralization were negative forTable 1
Variables signiﬁcantly associated with positive RRV ELISA IgG on univariate and multiv
Variable n (%) RRV seroprevalence
by ELISA IgG (%)
Un
Sex
Female 99 (50.5) 66.7 1 
Male 97 (49.5) 81.4 2.2
Birth year
1981–1993 (post-outbreak) 66 (33.7) 65.2 1 
1980 and before 129 (65.8) 78.3 1.9
Lived whole life in American Samoa
Yes 139 (70.9) 69.8 1
No 56 (28.6) 83.9 2.3
Occupation
Indoor 44 (22.4) 54.6 1 
Mixed indoor/outdoor 16 (8.2) 93.8 12
Outdoor 15 (7.7) 86.7 5.4
Cannery worker 21 (10.7) 90.5 7.9
Hiking
Never 116 (59.2) 67.2 1
Once a month or less 25 (12.8) 72.0 1.3
More than once a month 54 (27.6) 88.9 3.9
Gardening
Never 114 (58.2) 71.1 1 
Once a month or less 20 (10.2) 55.0 0.5
More than once a month 62 (31.6) 85.5 2.4
Total 196 (100) 74.0
RRV, Ross River virus; OR, odds ratio; CI, conﬁdence interval.
a Seroprevalence in those born post-outbreak and who had lived their whole lives in
b Statistically signiﬁcant odds ratio.CHIKV, conﬁrming that the ELISA-positive results were not due to
cross-reactions with this virus. No other alphaviruses are known to
have circulated in American Samoa prior to 2010, when the serum
samples were collected.
These ﬁndings are signiﬁcant considering that there are no
marsupials in American Samoa, implying that other animal species
are capable of acting as reservoirs to sustain endemic circulation.
This conclusion is consistent with serological evidence of RRV
circulation in French Polynesia,9 and infections in returned
travellers from other PICTs,7,8 where marsupials are also absent.
The information provided by the ELISA and neutralization tests
differs, and the discrepancies between the results may be
explained by the fact that, although detectable by ELISA, most of
the anti-RRV IgG only had limited neutralizing capacity. This
hypothesis is in accordance with the data presented in Figure 1ariable logistic regression analysis.a
ivariate OR (95% CI) p-Value Adjusted OR (95% CI) p-Value
1
b (1.1–4.3) 0.020 2.5b (1.1–5.5) 0.026
1
b (1.0–3.7) 0.050 2.1b (1.1–4.4) 0.045
b (1.0–5.0) 0.046
1
.5b (1.5–103.0) 0.019 8.8b (1.0–75.6) 0.047
b (1.1–26.9) 0.039 3.1 (0.6–17.1) 0.190




 (0.2–1.3) 0.159 1.1 (0.4–3.2) 0.907
b (1.1–5.4) 0.035 3.0b (1.2–7.3) 0.015
 American Samoa was 63.0%.
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higher the percentage of RRV-positive sera by neutralization.
This study included only samples from adults, so it is not
possible to know whether RRV has circulated recently in American
Samoa. However, the detection of imported cases from Fiji in
2009 and RRV seropositive persons living in French Polynesia since
2006 suggests that RRV may be circulating undetected in several
PICTs, possibly misdiagnosed as dengue virus (DENV), CHIKV, or
Zika virus (ZIKV) infections.15,16 Since RRV serology is not available
in most of the PICTs and because symptoms are variable and
overlap with other conditions, low-level RRV circulation could
occur undetected.
These ﬁndings have important ecological, clinical, and public
health implications, as they suggest that the geographic range of
RRV is larger than previously documented and includes areas
without marsupials. The animal species present in American
Samoa that may potentially act as amplifying hosts are rodents,
pigs, dogs, cats, and bats. There is insufﬁcient evidence based on
animal studies to implicate one or more of these as the speciﬁc
non-marsupial host(s), and ﬁeld-based animal studies are required
to clarify this situation. Rodents have been suggested as potentially
important in the transmission cycle based on epidemiological and
modelling studies,17,18 but pigs, dogs, cats, and bats were not
considered in these studies. Importantly, all ﬁve potential animal
reservoir hosts in American Samoa are pan-global in distribution,
suggesting that RRV could therefore spread well beyond its
currently known distribution.
Knowledge about the geographical range of pathogens is
important for empirical clinical diagnosis in the PICTs where
many infections have similar presentations, especially the
arboviruses that have been responsible for large outbreaks recently
(DENV, CHIKV, and ZIKV).15 A regional approach to RRV surveil-
lance is needed to improve understanding of disease ecology,
identify emergence and outbreaks, and develop effective strategies
to reduce the risk of global spread. The recent spread of ZIKV across
the PICTs19 and on to the Americas demonstrates that the potential
of global spread of emerging arboviruses from the Paciﬁc should
not be underestimated.
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